Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

330

Full text

287

Free full text

184

Publication Types

Journal Article

335

Research Support, Non-U.S. Gov't

150

Randomized Controlled Trial

129

Multicenter Study

117

Clinical Trial, Phase II

111

Clinical Trial, Phase III

Review

Research Support, N.I.H., Extramural

Comparative Study

Observational Study

Clinical Trial, Phase I

Clinical Trial

Meta-Analysis

Systematic Review

Case Reports

Editorial

Comment

Letter

Network Meta-Analysis

Equivalence Trial

Research Support, U.S. Gov't, Non-P.H.S.

Consensus Development Conference

Evaluation Study

Historical Article

Clinical Trial, Phase IV

Pragmatic Clinical Trial

Controlled Clinical Trial

Webcast

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2001

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Cetuximab""[mesh_terms]

342 Results

Searching titles within these results

Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal Cancer.

Michael Hier, Alex Mlynarek, Khashayar Esfahani, Moulay Alaoui-Jamali, Isis de Araújo Ferreira Muniz, Megan Araujo, Jenna Bouassaly, Fatemeh Farshadi, Mai Atique, Paulo Rogerio Ferreti Bonan, Marco Mascarella, Sabrina Daniela da Silva

International journal of molecular sciences 2024;25(7):

Free Full Text

Abstract

Taking it in the chin: vitamin K1 for the prevention of acneiform rash.

M E Lacouture

Annals of oncology : official journal of the European Society for Medical Oncology 2019;29(4):796-798

Free Full Text

Quantitative assessment of skin disorders induced by panitumumab: a prospective observational study.

Hiroaki Takahashi, Yoko Saito, Kanon Sugawara, Masaki Sato, Tomohiko Tairabune, Haruki Ujiie, Junichi Asaka, Kenzo Kudo

Cancer chemotherapy and pharmacology 2024;93(4):319-328

Full Text

Abstract

Targeted agents in older patients with gastrointestinal cancers - An overview.

Ana Raquel Monteiro, Rita Saúde Conde, Raquel Basto, Francesco Sclafani, Amélie Deleporte, Alain Hendlisz, Lissandra Dal Lago

Journal of geriatric oncology 2021;12(8):1240-1252

Full Text

Abstract

Role of nutritional status and intervention in oesophageal cancer treated with definitive chemoradiotherapy: outcomes from SCOPE1.

S Cox, C Powell, B Carter, C Hurt, Somnath Mukherjee, Thomas David Lewis Crosby

British journal of cancer 2017;115(2):172-7

Free Full Text

Abstract

Placebo-controlled phase II study of vitamin K3 cream for the treatment of cetuximab-induced rash.

Jens Overgaard, Jesper Grau Eriksen, Inger Kaalund, Ole Clemmensen, Per Pfeiffer

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2017;25(7):2179-2185

Full Text

Abstract

A triplet combination of FOLFOXIRI plus cetuximab as first-line treatment in RAS wild-type, metastatic colorectal cancer: a dose-escalation phase Ib study.

Shigenori Kadowaki, Toshiki Masuishi, Takashi Ura, Keiji Sugiyama, Seiichiro Mitani, Yukiya Narita, Hiroya Taniguchi, Kei Muro

International journal of clinical oncology 2021;26(4):701-707

Full Text

Abstract

A randomized study comparing the nutritional effects of radiotherapy with cetuximab versus cisplatin in patients with advanced head and neck cancer.

Ingvar Bosaeus, Ewa Silander, Jan Nyman, Mogens Bove, Leif Johansson, Eva Hammerlid, Malin Berg, Camilla Hansson, Hedda Haugen Cange

Head & neck 2024;46(4):760-771

Full Text

Abstract

Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial.

Valérie Boige, Hélène Blons, Eric François, Meher Ben Abdelghani, Jean-Marc Phelip, Valerie Le Brun-Ly, Laurent Mineur, Marie Pierre Galais, Anne-Laure Villing, Vincent Hautefeuille, Laurent Miglianico, Christelle De La Fouchardière, Dominique Genet, Nadia Levasseur, Charles-Briac Levaché, Nicolas Penel, Emmanuel Mitry, Stéphane Jacquot, Thomas Aparicio, Emilie Brument, Sophie Gourgou, Florence Castan, Olivier Bouché

JAMA network open 2023;6(9):e2333533

Free Full Text

Abstract

Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild-type metastatic colorectal cancer: A phase II trial (HYBRID).

Kohei Akiyoshi, Fumitaka Mizuki, Takuro Mizukami, Kathleen D Danenberg, Hiroyuki Arai, Narikazu Boku, Takako Eguchi Nakajima, Takashi Tsuda, Mototsugu Shimokawa, Shinya Tokunaga, Masahito Kotaka, Yu Sunakawa, Toshihiko Matsumoto, Hirokazu Shoji, Kenji Kunieda, Yusuke Nagata

Cancer medicine 2024;13(7):e7107

Free Full Text

Abstract

Management of radiodermatitis associated with cetuximab in squamous cell carcinomas of the head and neck.

Michelle Villavicencio, Martin Granados-García, Esther Vilajosana, Judith Domínguez-Cherit

International journal of dermatology 2018;56(6):602-609

Full Text

Abstract

A Systematic Review of Conversion to Resectability in Unresectable Metastatic Colorectal Cancer Chemotherapy Trials.

Sarah Chrabaszcz, Rahul Rajeev, Hunter D D Witmer, Ankit Dhiman, Brittany Klooster, T Clark Gamblin, Anjishnu Banerjee, Fabian M Johnston, Kiran K Turaga

American journal of clinical oncology 2022;45(8):366-372

Full Text

Abstract

Photoimmunotherapy for head and neck cancer: A systematic review.

Isaku Okamoto

Auris, nasus, larynx 2025;52(2):186-194

Full Text

Abstract

Reduced-dose of doublet chemotherapy combined with anti-EGFR antibodies in vulnerable older patients with metastatic colorectal cancer: Data from the REVOLT study.

Gerardo Rosati, Domenico Corsi, Antonio Avallone, Silvia Brugnatelli, Emanuela Dell'Aquila, Marika Cinausero, Giuseppe Aprile, Giuseppe Cicero, Chiara Carlomagno, Alfredo Colombo, Stefania Rapisardi, Carmine Pinto, Giorgio Reggiardo, Domenico Bilancia

Journal of geriatric oncology 2022;13(3):302-307

Full Text

Abstract

Extended physicochemical stability of cetuximab in opened vials and infusion bags when stored at 4°C and 25°C.

Victoire Vieillard, Guillaume Le Guyader, Alice Jallades, Alain Astier

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2024;30(1):142-150

Free Full Text

Abstract

Results: 1 – 15 / 342

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Cetuximab""[mesh_terms]

Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal Cancer.

Taking it in the chin: vitamin K1 for the prevention of acneiform rash.

Quantitative assessment of skin disorders induced by panitumumab: a prospective observational study.

Targeted agents in older patients with gastrointestinal cancers - An overview.

Role of nutritional status and intervention in oesophageal cancer treated with definitive chemoradiotherapy: outcomes from SCOPE1.

Placebo-controlled phase II study of vitamin K3 cream for the treatment of cetuximab-induced rash.

A triplet combination of FOLFOXIRI plus cetuximab as first-line treatment in RAS wild-type, metastatic colorectal cancer: a dose-escalation phase Ib study.

A randomized study comparing the nutritional effects of radiotherapy with cetuximab versus cisplatin in patients with advanced head and neck cancer.

Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial.

Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild-type metastatic colorectal cancer: A phase II trial (HYBRID).

Management of radiodermatitis associated with cetuximab in squamous cell carcinomas of the head and neck.

A Systematic Review of Conversion to Resectability in Unresectable Metastatic Colorectal Cancer Chemotherapy Trials.

Photoimmunotherapy for head and neck cancer: A systematic review.

Reduced-dose of doublet chemotherapy combined with anti-EGFR antibodies in vulnerable older patients with metastatic colorectal cancer: Data from the REVOLT study.

Extended physicochemical stability of cetuximab in opened vials and infusion bags when stored at 4°C and 25°C.

Results for
""Cetuximab""[mesh_terms]